BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21639912)

  • 1. HAPIscreen, a method for high-throughput aptamer identification.
    Dausse E; Taouji S; Evadé L; Di Primo C; Chevet E; Toulmé JJ
    J Nanobiotechnology; 2011 Jun; 9():25. PubMed ID: 21639912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking the emergence of high affinity aptamers for rhVEGF165 during capillary electrophoresis-systematic evolution of ligands by exponential enrichment using high throughput sequencing.
    Jing M; Bowser MT
    Anal Chem; 2013 Nov; 85(22):10761-70. PubMed ID: 24125636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancements in Aptamer Discovery Technologies.
    Gotrik MR; Feagin TA; Csordas AT; Nakamoto MA; Soh HT
    Acc Chem Res; 2016 Sep; 49(9):1903-10. PubMed ID: 27526193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of aptamer-target interactions by branched selection and high-throughput sequencing of SELEX pools.
    Dupont DM; Larsen N; Jensen JK; Andreasen PA; Kjems J
    Nucleic Acids Res; 2015 Dec; 43(21):e139. PubMed ID: 26163061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
    Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
    Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primer-free aptamer selection using a random DNA library.
    Pan W; Xin P; Patrick S; Dean S; Keating C; Clawson G
    J Vis Exp; 2010 Jul; (41):. PubMed ID: 20689511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
    Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
    J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAPID-SELEX for RNA aptamers.
    Szeto K; Latulippe DR; Ozer A; Pagano JM; White BS; Shalloway D; Lis JT; Craighead HG
    PLoS One; 2013; 8(12):e82667. PubMed ID: 24376564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple method for eliminating fixed-region interference of aptamer binding during SELEX.
    Ouellet E; Lagally ET; Cheung KC; Haynes CA
    Biotechnol Bioeng; 2014 Nov; 111(11):2265-79. PubMed ID: 24895227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer Bioinformatics.
    Kinghorn AB; Fraser LA; Lang S; Shiu SCC; Tanner JA
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of SELEX: comparison of different methods for monitoring the progress of in vitro selection of aptamers.
    Mencin N; Šmuc T; Vraničar M; Mavri J; Hren M; Galeša K; Krkoč P; Ulrich H; Šolar B
    J Pharm Biomed Anal; 2014 Mar; 91():151-9. PubMed ID: 24463043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial Intelligence in Aptamer-Target Binding Prediction.
    Chen Z; Hu L; Zhang BT; Lu A; Wang Y; Yu Y; Zhang G
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute quantification of cell-bound DNA aptamers during SELEX.
    Avci-Adali M; Wilhelm N; Perle N; Stoll H; Schlensak C; Wendel HP
    Nucleic Acid Ther; 2013 Apr; 23(2):125-30. PubMed ID: 23405949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of High-Throughput Sequencing (HTS) in Aptamer Selection Technology.
    Komarova N; Barkova D; Kuznetsov A
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of DNA aptamer against prostate specific antigen using a genetic algorithm and application to sensing.
    Savory N; Abe K; Sode K; Ikebukuro K
    Biosens Bioelectron; 2010 Dec; 26(4):1386-91. PubMed ID: 20692149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SELEX Modifications and Bioanalytical Techniques for Aptamer-Target Binding Characterization.
    Tan SY; Acquah C; Sidhu A; Ongkudon CM; Yon LS; Danquah MK
    Crit Rev Anal Chem; 2016 Nov; 46(6):521-37. PubMed ID: 26980177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment.
    Levay A; Brenneman R; Hoinka J; Sant D; Cardone M; Trinchieri G; Przytycka TM; Berezhnoy A
    Nucleic Acids Res; 2015 Jul; 43(12):e82. PubMed ID: 26007661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerating Post-SELEX Aptamer Engineering Using Exonuclease Digestion.
    Canoura J; Yu H; Alkhamis O; Roncancio D; Farhana R; Xiao Y
    J Am Chem Soc; 2021 Jan; 143(2):805-816. PubMed ID: 33378616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selection.
    Thiel WH; Bair T; Peek AS; Liu X; Dassie J; Stockdale KR; Behlke MA; Miller FJ; Giangrande PH
    PLoS One; 2012; 7(9):e43836. PubMed ID: 22962591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro RNA SELEX for the generation of chemically-optimized therapeutic RNA drugs.
    Urak KT; Shore S; Rockey WM; Chen SJ; McCaffrey AP; Giangrande PH
    Methods; 2016 Jul; 103():167-74. PubMed ID: 26972786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.